Delayed Graft Function Completed Phase 2 Trials for Tomaralimab (DB15415)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01794663Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft FunctionPrevention